Real world evidence (RWE) is fundamentally transforming the future of the life science sector in Sweden, at European level and globally. Unlike traditional research, RWE provides insights of what happens in the everyday clinical practice. This can deepen the understanding of how the individual patient and a heterogenous patient population will respond to a treatment, paving the way towards personalized treatment programs. Ultimately, improving treatment efficiency, safety, and patient and public health outcomes.
In Sweden under the leadership of Jenni Nordborg the Governments Life Science Office and the Life Science Strategy points out the direction for a robust resilient life science nation through improved utilization of health data where collaboration is one key to solve existing challenges that relates to Data Driven Systems of Care.
At EU-level, the European Commission has through the creation of the European Health Data Space (EHDS) declared that pan-European sharing of health data is one of its key priorities between 2019-2025 enabling member states to share data for public health, treatment, research, and innovation.
In Sweden, MSD CORE and the premier medical university Karolinska Institute have agreed to extend their existing partnership and master research agreement. The extension represents the commitment between a major US corporation active in Sweden on one side and a highly respected Swedish academic institution (KI being ranked no. 1 medical university within EU after Brexit) to continue a very fruitful collaboration which at the end of this contract period will have delivered important patient centered data and insights within Real World Evidence and registry research for 10 years.
Elsa Science offers a solution for Rheumatic Care Management where patient reported outcomes, from patients’ real world, are monitored remotely and utilized in care management by health care providers. Elsa Science’s service extends patient care beyond the clinic and offers richer assessments for quicker interventions. The objectives are to drive the transition to value-based care, enabling population health management as well as precision health on an individual level.
Against this background, this high-level breakfast event is organized to showcase how industry and academia partnerships, together with strong political national and EU commitment can accelerate the utilization of real-world evidence, registry research and advanced methodologies to improve patient care and population health outcomes. The event aim to put the spotlight on the challenges and pre-requisites for high quality partnership’s and all the opportunities it brings to contribute to a value based data driven health care system.
The agenda will include keynote speakers and a panel discussion followed by networking opportunities.
